<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03589404</url>
  </required_header>
  <id_info>
    <org_study_id>2011-KAEK-25 2018/04-24</org_study_id>
    <nct_id>NCT03589404</nct_id>
  </id_info>
  <brief_title>Effect of Pneumoperitoneum Anterior Abdominal Wall Tissue Oxygenation</brief_title>
  <official_title>Investigation of the Effect of Pneumoperitoneum Anterior Abdominal Wall Tissue Oxygenation on Laparoscopic Cholecystectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bursa Yüksek İhtisas Education and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bursa Yüksek İhtisas Education and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      During laparoscopic surgery, the abdomen is inflated with carbon dioxide for abdominal
      imaging and increased intraabdominal pressure affects intraabdominal structures and abdominal
      wall.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators aimed to investigate the effects of pneumoperitoneum administered during
      laparoscopic cholecystectomy on abdominal wall oxygenation and postoperative pain scores.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 15, 2018</start_date>
  <completion_date type="Actual">November 15, 2019</completion_date>
  <primary_completion_date type="Actual">November 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>prospective, cohort,double blind</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>investigator</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>rso2</measure>
    <time_frame>perioperative</time_frame>
    <description>The regional oxymetry probe (Medtronic Quick Assist INVOS™ (In-Vivo Optical Spectroscopy) Cerebral/Somatic Oximeter) will be placed in the abdominal region of the umbilicus in the middle clavicular line</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale</measure>
    <time_frame>Postoperative 24 hours</time_frame>
    <description>Visual Analog Scale was used for pain.Pain intensity was measured using 0-10 cm visual analogue scale (VAS). (0=no pain, 10=intolerable pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>analgesic use</measure>
    <time_frame>Postoperative 24 hours</time_frame>
    <description>analgesic use</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Laparoscopy</condition>
  <condition>Abdominal Wall</condition>
  <arm_group>
    <arm_group_label>rso2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The regional oxymetry probe will be placed in the abdominal region of the umbilicus in the middle clavicular line before the disease operation begins.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>rso2</intervention_name>
    <description>The regional oxymetry probe will be placed in the abdominal region of the umbilicus in the middle clavicular line before the disease operation begins.</description>
    <arm_group_label>rso2</arm_group_label>
    <other_name>abdominal wall tissue oxygenation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who were in the American Society of Anesthesiologists (ASA) I-III class

          -  Underwent laparoscopic cholecystectomy

        Exclusion Criteria:

          -  Previous surgeon surgeon

          -  Local anesthetic allergy,

          -  Bleeding is a diathesis disorder

          -  Mental impairment,

          -  Allergic to the drugs used,

          -  Patients who are not reluctant to participate in the study,

          -  Presence of infection in the block area,

          -  Patients whose body mass index is over 30
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Korgün Ökmen, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bursa Yuksek Ihtisas Training and Research Hospital</name>
      <address>
        <city>Bursa</city>
        <zip>16110</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>July 5, 2018</study_first_submitted>
  <study_first_submitted_qc>July 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 17, 2018</study_first_posted>
  <last_update_submitted>December 17, 2019</last_update_submitted>
  <last_update_submitted_qc>December 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bursa Yüksek İhtisas Education and Research Hospital</investigator_affiliation>
    <investigator_full_name>Korgün Ökmen</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumoperitoneum</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

